BackMyriad Genetics Overview
Myriad Genetics, Inc.

Myriad Genetics Target Price

See Myriad Genetics's analyst price targets ($2.7) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.19

Average Target Price

$2.6716.4% downside

3 analysts in the last 4 months

High: $3 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-01Piper Sandler$237.3% downsideOpen
2026-08-18Stephens$36% downsideOpen
2026-08-03Wells Fargo$36% downsideOpen
2026-02-24UBSLu Li$688.1% upsideOpen
2025-11-04UBSLu Li$8150.8% upsideOpen
2025-05-07Craig-HallumBill Bonello$18464.3% upsideOpen
2025-05-07UBSLu Li$7119.4% upsideOpen
2025-05-07Wells FargoBrandon Couillard$688.1% upsideOpen
2025-03-12Piper Sandler$12.5291.8% upsideOpen
2025-03-04Piper Sandler$11.5260.5% upsideOpen
2024-12-09Leerink PartnersPuneet Souda$21558.3% upsideOpen
2024-10-14ScotiabankSung Ji Nam$34965.8% upsideOpen
2024-09-19Morgan StanleyTejas Savant$32903.1% upsideOpen
2024-08-27Wells FargoBrandon Couillard$35997.2% upsideOpen
2024-08-07GuggenheimSubbu Nambi$29809.1% upsideOpen
2024-06-26ScotiabankSung Ji Nam$29809.1% upsideOpen
2024-05-13Piper SandlerJon Peterson$28777.7% upsideOpen
2023-12-21Piper SandlerDavid Westenberg$23621% upsideOpen
2022-10-05StephensMason Carrico$22589.7% upsideOpen
2022-04-19Goldman Sachs$23621% upsideOpen

Myriad Genetics (MYGN) FAQ

As of the most recent data, MYGN shows a target price of $2.7. Scroll down for historical charts and peer comparison views.

If Myriad Genetics moved to the average analyst target of $2.7, shares would be roughly 16.4% lower than $3.19. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Myriad Genetics's earnings trajectory.

Besides this target price page, Stockcircle has Myriad Genetics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $2.7) with ownership activity and broader fundamentals.

Myriad Genetics's target price is $2.7; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.